Prof Erik Stroes is a vascular internist with a longstanding track of research in the field of lipidology, inflammation and atherosclerosis. Current research foci encompass the use of CT-angiography as a guide to tailored treatment regimens, pathophysiology of Lp(a) in atherogenesis and anti-inflammatory strategies in high cardiovascular risk patients.
He is leading the lipid-clinic at AmsterdamUMC in the Netherlands. He has co-authored more than 540 peer-reviewed articles in the field of atherogenesis, (familial) hypercholesterolemia and cardiovascular treatment. He is Chair of the Dutch foundation aiming to optimize screening for familial hypercholesterolemia (LEEFH) and involved in several landmark trials in the cardiovascular arena.

Contributions

Multi-omics in CV-medicine92nd EAS Congress 2024Plenary 03"Fire and Forget" Time to say Goodbye?92nd EAS Congress 2024CME session 2LCN Lp(a) webinar series #3: Recommendations for Lp(a) screeningWebinars on-demandReimagining population health-the time is now - Discussion and Q&AReimagining population health-the time is now90th EAS Congress 2022Who will benefit most from PCSK9i?89th EAS Congress 2021(Anti PCSK9ReviewCholesterolTreatmentHypolipidemic drugs)Is there a role for Advanced Atherosclerosis Imaging in targeted cardiovascular therapy?EAS 2017 AC on Precision Medicine in ANew lipid drugs - Is LDL done, ready for new targets?87th EAS Congress 2019Lipids, inflammation and CV risk86th EAS Congress 2018